OpenURL Connection Search

Select item for more details and to access through your institution.

High-sensitive basal serum thyroglobulin 6-12 months after thyroid ablation is strongly associated with early response to therapy and event-free survival in patients with low-to-intermediate risk differentiated thyroid carcinomas.
Published in:
European Journal of Endocrinology, 2017, v. 176, n. 5, p. 497, doi. 10.1530/EJE-16-1011
By:
- Trimboli, P.;
- Zilioli, V.;
- Imperiali, M.;
- Ceriani, L.;
- Giovanella, L.
Publication type:
Article
DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN LATE‐OCTOGENARIAN (LO) PATIENTS: A SUBSTUDY OF THE “ELDERLY PROJECT” BY THE FONDAZIONE ITALIANA LINFOMI (FIL)
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.95_2880
By:
- Tucci, A.;
- Merli, F.;
- Fabbri, A.;
- Mancuso, S.;
- Sartori, R.;
- Storti, S.;
- Luminari, S.;
- Mammi, C.;
- Marcheselli, L.;
- Arcari, A.;
- Cavallo, F.;
- Zilioli, V. R.;
- Bottelli, C.;
- Re, A.;
- Gini, G.;
- Cox, M. C.;
- Puccini, B.;
- Pagani, C.;
- Balzarotti, M.;
- Spina, M.
Publication type:
Article
AUTOLOGOUS TRANSPLANT IN ELDERLY PATIENTS WITH R/R AGGRESSIVE LYMPHOMA SELECTED BY SIMPLIFIED CGA: THE RECANZ PROSPECTIVE PHASE 2 STUDY BY THE FONDAZIONE ITALIANA LINFOMI.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.99_2880
By:
- Tucci, A;
- Musuraca, G;
- Cavallo, F;
- Zilioli, V. R;
- Zanni, M;
- Pelliccia, S;
- Mannina, D;
- Michieli, M;
- Vallisa, D;
- Tani, M;
- Merli, F;
- Re, F;
- Marcheselli, L;
- Campostrini, G;
- Pagani, C;
- Grimaldi, D;
- Liardo, E. V;
- Re, A;
- Cox, M. C;
- Rossi, G
Publication type:
Article
BRENTUXIMAB VEDOTIN CONSOLIDATION AFTER AUTOLOGOUS STEM CELLS TRANSPLANTATION FOR HODGKIN LYMPHOMA: A REAL‐LIFE EXPERIENCE BY FONDAZIONE ITALIANA LINFOMI (FIL)
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.65_2881
By:
- Massaro, F.;
- Pavone, V.;
- Stefani, P. M.;
- Botto, B.;
- Pulsoni, A.;
- Patti, C.;
- Cantonetti, M.;
- Visentin, A.;
- Scalzulli, P. R.;
- Rossi, A.;
- Galimberti, S.;
- Cimminiello, M.;
- Gini, G.;
- Musso, M.;
- Sorio, M.;
- Arcari, A.;
- Zilioli, V. R.;
- Bari, A.;
- Mannina, D.;
- Fabbri, A.
Publication type:
Article
IMPACT OF DIFFERENT INDUCTION REGIMENS ON THE OUTCOME OF PRIMARY MEDIASTINAL B CELL LYMPHOMA IN THE PROSPECTIVE IELSG 37 TRIAL.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.49_2879
By:
- Martelli, M.;
- Zucca, E.;
- Botto, B.;
- Kryachok, I.;
- Ceriani, L.;
- Balzarotti, M.;
- Tucci, A.;
- Cabras, M. G.;
- Zilioli, V. R.;
- Rusconi, C.;
- Angrilli, F.;
- Arcaini, L.;
- Iwanicka, A. Dabrowska;
- Ferreri, Andrés J.M.;
- Merli, F.;
- Zhao, W.;
- Hodgson, D.;
- Ionescu, C.;
- Fosså, A.;
- Cwynarski, K.
Publication type:
Article
UPDATED RESULTS OF THE FIL “MIRO” STUDY, A MULTICENTER PHASE II TRIAL COMBINING LOCAL RADIOTHERAPY AND MRD‐DRIVEN IMMUNOTHERAPY IN EARLY‐STAGE FOLLICULAR LYMPHOMA.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.31_2880
By:
- Pulsoni, A.;
- Tosti, M. E.;
- Ferrero, S.;
- Luminari, S.;
- Dondi, A.;
- Liberati, A. M.;
- Cenfra, N.;
- Renzi, D.;
- Zanni, M.;
- Boccomini, C.;
- Ferreri, A. J.;
- Rattotti, S.;
- Zilioli, V. R.;
- Bernuzzi, P.;
- Bolis, S.;
- Musuraca, G.;
- Nassi, L.;
- Perrone, T.;
- Stelitano, C.;
- Anastasia, A.
Publication type:
Article
UPDATED RESULTS OF THE FIL “MIRO” STUDY, A MULTICENTER PHASE II TRIAL COMBINING LOCAL RADIOTHERAPY AND MRD‐DRIVEN IMMUNOTHERAPY IN EARLY‐STAGE FOLLICULAR LYMPHOMA.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.30_2880
By:
- Pulsoni, A.;
- Tosti, M. E.;
- Ferrero, S.;
- Luminari, S.;
- Dondi, A.;
- Liberati, A. M.;
- Cenfra, N.;
- Renzi, D.;
- Zanni, M.;
- Boccomini, C.;
- Ferreri, A. J.;
- Rattotti, S.;
- Zilioli, V. R.;
- Bernuzzi, P.;
- Bolis, S.;
- Musuraca, G.;
- Nassi, L.;
- Perrone, T.;
- Stelitano, C.;
- Anastasia, A.
Publication type:
Article
ROMIDEPSIN‐CHOEP PLUS UP‐FRONT STEM‐CELL TRANSPLANTATION IN PERIPHERAL T‐CELL LYMPHOMA (PTCL): FIRST ANALYSIS OF THE PHASE II FIL‐PTCL13 STUDY.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.130_2880
By:
- Chiappella, A.;
- Carniti, C.;
- Re, A.;
- Castellino, C.;
- Evangelista, A.;
- Ciancia, R.;
- Orsucci, L.;
- Pinto, A.;
- Usai, S. V.;
- Arcari, A.;
- Ilariucci, F.;
- Rossi, F. G.;
- Benedetti, F.;
- Flenghi, L.;
- Ghiggi, C.;
- Molinari, A. L.;
- Stefoni, V.;
- Volpetti, S.;
- Zilioli, V. R.;
- Ballerini, F.
Publication type:
Article
SARCOPENIA IS AN INDEPENDENT PROGNOSTIC FACTOR IN ELDERLY MALE PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA: RESULTS FROM A MULTICENTER EXPERIENCE.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.116_2880
By:
- Zilioli, V. R.;
- Albano, D.;
- Arcari, A.;
- Merli, F.;
- Coppola, A.;
- Besutti, G.;
- Marcheselli, L.;
- Gramegna, D.;
- Muzi, C.;
- Manicone, M.;
- Camalori, M.;
- Ciammella, P.;
- Colloca, G.;
- Tucci, A.
Publication type:
Article
LENALIDOMIDE AND RITUXIMAB (ReRi) AS FRONT LINE THERAPY OF ELDERLY FRAIL PATIENTS WITH DIFFUSE LARGE B‐CELLS LYMPHOMA. FIRST PLANNED INTERIM ANALYSIS OF A PHASE II STUDY OF THE FONDAZIONE ITALIANA LINFOMI (FIL).
Published in:
Hematological Oncology, 2019, v. 37, p. 427, doi. 10.1002/hon.99_2631
By:
- Gini, G.;
- Tani, M.;
- Bassan, R.;
- Tucci, A.;
- Ballerini, F.;
- Sampaolo, M.;
- Merli, F.;
- Re, F.;
- Annibali, O.;
- Liberati, A.;
- Visco, C.;
- Arcari, A.;
- Storti, S.;
- Fabbri, A.;
- Musuraca, G.;
- Zilioli, V.;
- Cox, M.;
- Luminari, S.
Publication type:
Article
GRANISETRON TRANSDERMAL DELIVERY SYSTEM USE IN LYMPHOPROLIFERATIVE DISEASE: A SINGLE CENTER EXPERIENCE.
Published in:
Hematological Oncology, 2019, v. 37, p. 540, doi. 10.1002/hon.227_2631
By:
- Minga, P.;
- Muzi, C.;
- Zilioli, V.;
- Meli, E.;
- Rusconi, C.;
- Deodato, M.;
- Cairoli, R.
Publication type:
Article
LENALIDOMIDE AND RITUXIMAB (ReRi) AS FRONT LINE THERAPY OF ELDERLY FRAIL PATIENTS WITH DIFFUSE LARGE B‐CELLS LYMPHOMA. FIRST PLANNED INTERIM ANALYSIS OF A PHASE II STUDY OF THE FONDAZIONE ITALIANA LINFOMI (FIL).
Published in:
Hematological Oncology, 2019, v. 37, p. 427, doi. 10.1002/hon.99_2631
By:
- Gini, G.;
- Tani, M.;
- Bassan, R.;
- Tucci, A.;
- Ballerini, F.;
- Sampaolo, M.;
- Merli, F.;
- Re, F.;
- Annibali, O.;
- Liberati, A.;
- Visco, C.;
- Arcari, A.;
- Storti, S.;
- Fabbri, A.;
- Musuraca, G.;
- Zilioli, V.;
- Cox, M.;
- Luminari, S.
Publication type:
Article
GRANISETRON TRANSDERMAL DELIVERY SYSTEM USE IN LYMPHOPROLIFERATIVE DISEASE: A SINGLE CENTER EXPERIENCE.
Published in:
Hematological Oncology, 2019, v. 37, p. 540, doi. 10.1002/hon.227_2631
By:
- Minga, P.;
- Muzi, C.;
- Zilioli, V.;
- Meli, E.;
- Rusconi, C.;
- Deodato, M.;
- Cairoli, R.
Publication type:
Article

Found: 13